Genmab to shutter U.S. plant, cut 300 jobs

Denmark-based Genmab plans to cut some 300 jobs and sell off a U.S. manufacturing plant as it downgrades its expectations for 2009 sales for the second time; "cost pressures" in the pharma industry "will be permanent," CEO Lisa Drakeman said. Report